Old Web
English
Sign In
Acemap
>
authorDetail
>
Natsuko Okita Tsuda
Natsuko Okita Tsuda
Cisplatin
Medicine
Palonosetron
Clinical endpoint
Aprepitant
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable esophagogastric junction adenocarcinoma: A retrospective study.
2021
Journal of Clinical Oncology
Toshiharu Hirose
Shun Yamamoto
Kotoe Oshima
Hidekazu Hirano
Natsuko Okita Tsuda
Hirokazu Shoji
Satoru Iwasa
Yoshitaka Honma
Atsuo Takashima
Narikazu Boku
Zyunya Oguma
Koshiro Ishiyama
Hiroyuki Daiko
Ken Kato
Show All
Source
Cite
Save
Citations (0)
A double-blind randomized phase II study of 10 versus 5 mg olanzapine for emesis induced by highly emetogenic chemotherapy with cisplatin.
2016
Journal of Clinical Oncology
Hironobu Hashimoto
Takako Yanai
Kengo Nagashima
Natsuko Okita Tsuda
Hidehito Horinouchi
Tomomi Takiguchi
Fumiyoshi Ohyanagi
Masahiko Nakao
Koji Takeda
Toshiaki Nakayama
Hiroshi Sakai
Takahiro Arai
Koichi Minato
Y. Kogure
Daijiro Harada
Kenichi Suzuki
Narikazu Boku
Yasuhiro Shimada
Satoru Iwasa
Noboru Yamamoto
Show All
Source
Cite
Save
Citations (10)
1